EUVIMEDEUVIMED entdecken
Crossref

Thrombospondin‐1 mimic peptide PKHB1 induced endoplasmic reticulum stress‐mediated but CD47‐independent apoptosis in non‐small cell lung cancer

Jiani Ye, Yinan Yao, Jianfeng Zhao, Luyun Cui, Guohua Lu, Qing Wang, Pei Zhang, Jianying Zhou iD

Drug Development Research · 2023

DOI: 10.1002/ddr.22028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2023. Verfasst von Jiani Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐small cell lung cancer (NSCLC) is one of the most common malignancies with high morbidity and mortality. PKHB1, a serum‐stable Thrombospondin‐1 (TSP‐1) mimic peptide, has shown some effective ability in triggering cell death against several cancers. Here, we aimed to study the potential biological function of PKHB1 and its molecular mechanism in NSCLC. Our results revealed that PKHB1 significantly suppressed NSCLC cell proliferation, cell migration, and induced apoptosis in a dose‐dependent manner. Additionally, we found that PKHB1 treatment resulted in mitochondrial transmembrane potential depolarization, Ca 2+ overloading as well as the upregulation of proapoptotic proteins. Mechanistically, PKHB1 induced NSCLC cells apoptosis in a CD47‐independent manner. Further study revealed that PKHB1 provoked endoplasmic reticulum (ER) stress principally through the activation of CHOP and JNK signaling, which could be alleviated in the presence of 4‐PBA, an ER stress inhibitor. Furthermore, xenograft tumor models showed that PKHB1 treatment could notably inhibit NSCLC tumor growth in vivo. In conclusion, these findings suggested that PKHB1 exerted antitumor efficacy in NSCLC via triggering ER stress‐mediated but CD47‐independent apoptosis, potentially functioned as a promising peptide‐based therapeutic agent for NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansThrombospondin 1CD47 AntigenApoptosisEndoplasmic Reticulum StressPeptidesCell Line, Tumor

Stichwörter der Autor:innen

CD47ER stressNSCLCPKHB1TSP-1apoptosis

Substanzen

Thrombospondin 1CD47 AntigenPeptidesCD47 protein, human

Autor:innen und Institutionen

  • Department of Respiratory Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Respiratory Diseases, People's Hospital of Jingning She Autonomous County, Lishui, China.

ORCID-Profile: Jianying Zhou

Zitieren

APA

Ye, J., Yao, Y., Zhao, J., Cui, L., Lu, G., Wang, Q., Zhang, P., & Zhou, J. (2023). Thrombospondin‐1 mimic peptide PKHB1 induced endoplasmic reticulum stress‐mediated but CD47‐independent apoptosis in non‐small cell lung cancer. Drug Development Research. https://doi.org/10.1002/ddr.22028

Vancouver

Ye J, Yao Y, Zhao J, Cui L, Lu G, Wang Q, et al. Thrombospondin‐1 mimic peptide PKHB1 induced endoplasmic reticulum stress‐mediated but CD47‐independent apoptosis in non‐small cell lung cancer. Drug Development Research. 2023. doi:10.1002/ddr.22028

BibTeX
@article{Ye2023,
  author = {Ye, Jiani and Yao, Yinan and Zhao, Jianfeng and Cui, Luyun and Lu, Guohua and Wang, Qing and Zhang, Pei and Zhou, Jianying},
  title = {Thrombospondin‐1 mimic peptide PKHB1 induced endoplasmic reticulum stress‐mediated but CD47‐independent apoptosis in non‐small cell lung cancer},
  journal = {Drug Development Research},
  year = {2023},
  doi = {10.1002/ddr.22028}
}
Kostenlos starten →